Search - tctmd.com

Displaying 561 - 580 of 1453

Sort: Relevancy | Date

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Industry News

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

July 15, 2019

News Daily News

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Michael O'Riordan

July 12, 2019

News Daily News

Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR

Yael L. Maxwell

July 11, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Industry News

BIOTRONIK Receives FDA Clearance on Next-Gen Injectable Cardiac Monitor: BIOMONITOR III

July 08, 2019

News Daily News

Fragmented TAVR Care Common, Linked to Death and Readmission

L.A. McKeown

July 08, 2019

Podcast TCTMD Talking Points

NEOPRO: Nonrandomized Comparison of Two Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

July 03, 2019

News Daily News

Life Expectancy Post-SAVR Varies by Age, Raising Questions for Treatment Timing

Caitlin E. Cox

July 01, 2019

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Opinion Fellow Talk

Hemodynamics: The Forgotten Branch of Cardiology

Mesfer Alfadhel, MD

June 28, 2019

News Daily News

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Shelley Wood

June 27, 2019

News Daily News

CMS Releases Final Decision Memo on Rules for TAVR Program Reimbursement

Shelley Wood

June 24, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Featured Fellow

Amir Azarbal, MD

Yael L. Maxwell

June 20, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Shelley Wood

June 19, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Daily News

Ischemic Events Worsen Long-term Cognitive Decline

Yael L. Maxwell

June 18, 2019

Advertisement

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

BIOTRONIK Receives FDA Clearance on Next-Gen Injectable Cardiac Monitor: BIOMONITOR III

Fragmented TAVR Care Common, Linked to Death and Readmission

NEOPRO: Nonrandomized Comparison of Two Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

Life Expectancy Post-SAVR Varies by Age, Raising Questions for Treatment Timing

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

TCTMD’s Top 10 Most Popular Stories for June 2019

Hemodynamics: The Forgotten Branch of Cardiology

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

CMS Releases Final Decision Memo on Rules for TAVR Program Reimbursement

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Amir Azarbal, MD

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Ischemic Events Worsen Long-term Cognitive Decline

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content